Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease (original) (raw)

Molecular Psychiatry volume 7, pages 136–137 (2002)Cite this article

SIR – Alzheimer's disease (AD) is a chronic brain disorder associated with specific pathological changes resulting in neurodegeneration and in progressive development of dementia. This disease is clinically characterized by memory, reasoning and speech disorders and pathologically by the presence of senile plaques (SP), neurofibrillary tangles, and loss of synapses.1 There are various hypotheses regarding an involvement of genetic factors in the development of AD. Mutations of genes encoding amyloid precursor protein, presenilin-1 and presenilin-2 cause familial AD,2,3 and the ε4 allele of apolipoprotein E (APOE) gene gives susceptibility to familial and sporadic AD.4 However, this genetic marker cannot explain the overall genetic susceptibility and additional/other genes may be involved in the development of AD.

Genes involved in the neurodevelopmental process may be considered good candidates to confer susceptibility to AD. Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of growth factors which promotes survival, differentiation and maintenance of neurons in peripheral and central nervous system during normal development,5 influences axonal growth and connectivity6 and participates in the local responses to various types of neuronal stress or insults.7

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Katzman R et al. In: Terry RD et al (eds) Alzheimer's Disease Raven Press: New York 1994 105–122
    Google Scholar
  2. Levy-Lahad E et al. Science 1995 269: 973–977
    Article CAS Google Scholar
  3. Finckh U et al. Neurology 2000 54: 2006–2008
    Article CAS Google Scholar
  4. Saunders AM et al. Neurology 1993 43: 1467–1472
  5. Lewin GR et al. Annu Rev Neurosci 1996 19: 289–317 (Review)
  6. Segal RA et al. J Neurosci 1995 15: 4970–4981
  7. Ferrer I et al. Brain Pathol 1998 8: 253–261
  8. Ferrer I et al. J Neuropathol Exp Neurol 1999 58: 729–739
  9. Kunugi H et al. Mol Psychiatry 2001 6: 83–86

Download references

Author information

Authors and Affiliations

  1. Genetics Unit, IRCCS ‘S Giovanni di Dio’, Fatebenefratelli, Brescia, 25100, Italy
    M Ventriglia, L Bocchio Chiavetto & M Gennarelli
  2. Neurobiology Laboratory, IRCCS ‘S Giovanni di Dio’, Fatebenefratelli, Brescia, 25100, Italy
    L Benussi & G Binetti
  3. Alzheimer Unit, IRCCS ‘S Giovanni di Dio’, Fatebenefratelli, Brescia, 25100, Italy
    G Binetti & O Zanetti
  4. Center of Neuropharmacology, Institute of Pharmacological Sciences, University of Milan, Milan, 20100, Italy
    M A Riva

Authors

  1. M Ventriglia
    You can also search for this author inPubMed Google Scholar
  2. L Bocchio Chiavetto
    You can also search for this author inPubMed Google Scholar
  3. L Benussi
    You can also search for this author inPubMed Google Scholar
  4. G Binetti
    You can also search for this author inPubMed Google Scholar
  5. O Zanetti
    You can also search for this author inPubMed Google Scholar
  6. M A Riva
    You can also search for this author inPubMed Google Scholar
  7. M Gennarelli
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toM Gennarelli.

Rights and permissions

About this article

Cite this article

Ventriglia, M., Bocchio Chiavetto, L., Benussi, L. et al. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease.Mol Psychiatry 7, 136–137 (2002). https://doi.org/10.1038/sj.mp.4000952

Download citation

This article is cited by